HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis

GR Mumtaz, HA Weiss, SL Thomas, S Riome… - PLoS …, 2014 - journals.plos.org
Background It is perceived that little is known about the epidemiology of HIV infection among
people who inject drugs (PWID) in the Middle East and North Africa (MENA). The primary …

[HTML][HTML] Epidemiology of hepatitis C virus in Iran

R Taherkhani, F Farshadpour - World Journal of Gastroenterology …, 2015 - ncbi.nlm.nih.gov
In Iran, the prevalence of hepatitis C virus (HCV) infection is relatively low according to the
population-based epidemiological studies. However, the epidemiology of HCV is changing …

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis

SJ Shayan, R Nazari, F Kiwanuka - Harm reduction journal, 2021 - Springer
Abstract Background HIV and Hepatitis C Virus (HCV) infections are responsible for a
significant burden of mortality and morbidity, particularly in developing countries. This study …

[HTML][HTML] High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001–2012)

M Malekinejad, S Navadeh, A Lotfizadeh… - International Journal of …, 2015 - Elsevier
Objective Drug users, particularly drug injectors, are at elevated risk of blood-borne
diseases. This study systematically reviewed the prevalence of hepatitis C virus (HCV) mono …

SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic …

S Merat - Clinical infectious diseases, 2020 - academic.oup.com
Background The combination of sofosbuvir and daclatasvir is a potent, pangenotypic
regimen suitable for mass-scale hepatitis C treatment, especially in resource-limited …

A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran

M Behzadifar, M Behzadifar, NL Bragazzi - BMC Public Health, 2020 - Springer
Abstract Background Hepatitis C virus (HCV) infection is one of the major public health
challenges generating a relevant burden. High-risk groups, including people who inject …

Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa

GR Mumtaz, HA Weiss, P Vickerman, N Larke… - Aids, 2015 - journals.lww.com
Objectives: The objective of this study is to understand the association between HIV and
hepatitis C virus (HCV) among people who inject drugs (PWIDs) in the Middle East and …

Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil

K Adeboyejo, VR Grosche, DP José… - Access …, 2022 - microbiologyresearch.org
Hepatitis C virus (HCV) is responsible for more than 180 million infections worldwide, and
about 80% of infections are reported in Low and Middle-income countries (LMICs). Therapy …

Perceived risk modifies the effect of HIV knowledge on sexual risk behaviors

G Noroozinejad, M Yarmohmmadi Vasel… - Frontiers in public …, 2013 - frontiersin.org
Background: There is a large controversy in the literature about the inter-relations between
perceived risk, knowledge, and risk behavior in different settings, and people at HIV risk are …

Unprotected anal intercourse among Iranian intra-venous drug users

P Mirabi, M Yarmohmmadi Vasel, B Moazen… - Frontiers in Public …, 2013 - frontiersin.org
Purpose: To assess the prevalence and associated factors of unprotected anal intercourse
among Iranian male heterosexual Intra-Venous Drug Users (IDUs). Methods: In a cross …